Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001897612-25-000555·Prime Medicine, Inc.
Schedule 13G ownership disclosure
Prime Medicine Inc
COMMON STOCK · CUSIP: 74168J101
Event date: 2025-09-30
- Filing-level shares
- 9,236,955
- Percent of class
- 5.3%
- T. Rowe Price Investment Management, Inc.
Shares: 9,236,955 · Class: 5.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001897612-25-000555
- Form type
- SCHEDULE 13G
- Filer
- Prime Medicine, Inc.
- CIK
- CIK 1894562
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership